Cardlytics, Inc. (NASDAQ:CDLX) CFO Alexis Desieno Sells 7,324 Shares

Cardlytics, Inc. (NASDAQ:CDLX) CFO Alexis Desieno sold 7,324 shares of the stock in a transaction that occurred on Wednesday, July 2nd. The stock was sold at an average price of $1.78, for a total transaction of $13,036.72. Following the completion of the sale, the chief financial officer directly owned 171,858 shares of the company’s stock, valued at $305,907.24. This trade represents a 4.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Cardlytics Price Performance

Shares of CDLX opened at $1.87 on Friday. The company has a debt-to-equity ratio of 2.62, a quick ratio of 1.19 and a current ratio of 1.19. The firm has a market cap of $97.91 million, a PE ratio of -0.52 and a beta of 1.21. The firm’s 50 day moving average price is $1.80 and its 200 day moving average price is $2.39. Cardlytics, Inc. has a twelve month low of $1.22 and a twelve month high of $9.48.

Analysts Set New Price Targets

Several research analysts have weighed in on CDLX shares. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research note on Thursday, March 13th. Evercore ISI dropped their price target on shares of Cardlytics from $4.00 to $3.00 and set an “in-line” rating on the stock in a research note on Thursday, March 13th. Finally, Lake Street Capital reduced their price objective on Cardlytics from $3.00 to $2.50 and set a “hold” rating for the company in a research report on Thursday, May 8th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $3.50.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Intech Investment Management LLC lifted its stake in shares of Cardlytics by 31.3% in the 4th quarter. Intech Investment Management LLC now owns 19,310 shares of the company’s stock valued at $72,000 after purchasing an additional 4,607 shares during the last quarter. Wells Fargo & Company MN raised its holdings in Cardlytics by 46.0% during the fourth quarter. Wells Fargo & Company MN now owns 21,106 shares of the company’s stock valued at $78,000 after buying an additional 6,649 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Cardlytics by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 1,060,739 shares of the company’s stock worth $3,936,000 after buying an additional 7,561 shares during the last quarter. Brooktree Capital Management lifted its position in shares of Cardlytics by 4.5% in the fourth quarter. Brooktree Capital Management now owns 175,210 shares of the company’s stock worth $650,000 after buying an additional 7,568 shares during the last quarter. Finally, Two Sigma Investments LP boosted its stake in shares of Cardlytics by 12.5% during the 4th quarter. Two Sigma Investments LP now owns 94,901 shares of the company’s stock worth $352,000 after acquiring an additional 10,508 shares in the last quarter. Institutional investors and hedge funds own 68.10% of the company’s stock.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.